Instrument NameNovocure Ltd Ord ShInstrument Symbol(NVCR-Q)

Instrument ExchangeNASDAQ

Novocure announced encouraging results in a phase 3 trial for its TTFields therapy.

Novocure had good news mixed with some not-so-good news.

The S&P 500 Index ($SPX ) (SPY ) Wednesday closed up +0.86%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.22%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. Stock indexes on Wednesday finished moderately higher. Lower T-note yields on Wednesday were supportive...

Stocks that traded heavily or had substantial price changes on Wednesday: Merck, Cintas rise; GameStop, MiMedx fall

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.31%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.63%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.09%. Stock indexes this morning are mixed. Lower T-note yields today are supportive of...

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.52%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.78%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.25%. Stock indexes this morning are moderately higher as T-note yields slipped. End-of-quarter rebalancing...

NVCR earnings call for the period ending December 31, 2023.

The stock isn't far from its 52-week low.

Investors weren't particularly pleased with the company's third-quarter performance.

NVCR earnings call for the period ending September 30, 2023.

Its cancer-treating device is struggling to find its market.

It's entering a risky period, but it could persevere.

Novocure announced a disappointing outcome from a phase 3 clinical trial for a key cancer treatment.

It can be hard to find a reason to remain bullish on NovoCure.

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.62%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.74%. Stocks on Monday posted moderate gains. Stocks moved higher...

Stocks that traded heavily or had substantial price changes on Monday: 3M, Boston Scientific rise; Abcam, NovoCure fall

The company disappointed investors with its latest clinical trial update.

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.35%. Stocks this morning are moderately higher. Stocks are moving...

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.45%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.59%. Stock indexes this morning are moderately higher on some positive carryover from last Friday’s neutral comments from Fed Chair Powell, who said the Fed is...

The stock has some significant upside, but it also comes with considerable risks and volatility.

/PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action...

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in NovoCure Limited ("NovoCure" or the "Company") (NASDAQ: NVCR) of a class action securities lawsuit....

/PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NovoCure Limited (NASDAQ: NVCR) between January 5,...

/PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of NovoCure Limited (NASDAQ: NVCR) alleging...

/PRNewswire/ -- Attention NovoCure Limited ("NovoCure") (NASDAQ: NVCR) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has...